Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Acer Therapeutics Inc. (ACER) been one of those stocks this year? A quick glance at the company’s year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Acer Therapeutics Inc. is a member of our Medical group, which includes 1183 different companies and currently sits at #3 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Acer Therapeutics Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ACER’s full-year earnings has moved 36.9% higher. This signals that analyst sentiment is improving and the stock’s earnings outlook is more positive.
According to our latest data, ACER has moved about 28.1% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -15.6% on a year-to-date basis. This shows that Acer Therapeutics Inc. is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Cardinal Health (CAH). The stock is up 54.4% year-to-date.
For Cardinal Health, the consensus EPS estimate for the current year has increased 0.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Acer Therapeutics Inc. belongs to the Medical – Drugs industry, which includes 218 individual stocks and currently sits at #84 in the Zacks Industry Rank. This group has lost an average of 29.7% so far this year, so ACER is performing better in this area.
In contrast, Cardinal Health falls under the Medical – Dental Supplies industry. Currently, this industry has 18 stocks and is ranked #209. Since the beginning of the year, the industry has moved -11.2%.
Investors interested in the Medical sector may want to keep a close eye on Acer Therapeutics Inc. and Cardinal Health as they attempt to continue their solid performance.
Free Report Reveals How You Could Profit from the Growing Electric Vehicle Industry
Globally, electric car sales continue their remarkable growth even after breaking records in 2021. High gas prices have fueled his demand, but so has evolving EV comfort, features and technology. So, the fervor for EVs will be around long after gas prices normalize. Not only are manufacturers seeing record-high profits, but producers of EV-related technology are raking in the dough as well. Do you know how to cash in? If not, we have the perfect report for you – and it’s FREE! Today, don’t miss your chance to download Zacks’ top 5 stocks for the electric vehicle revolution at no cost and with no obligation.
>>Send me my free report on the top 5 EV stocks
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report